Clinical Liver Disease
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 111:15:50
- Mais informações
Informações:
Sinopse
Clinical Liver Disease (CLD), an official digital learning resource of The American Association for the Study of Liver Diseases is an interactive, up-to-date source of education, designed for physicians and healthcare providers caring for the patient with liver disease. CLD provides current and clinically relevant information through educational interventions every two months.
Episódios
-
![The Price of Shortening Anti–Hepatitis C Virus Therapy: Is This Truly Cost Saving?]()
The Price of Shortening Anti–Hepatitis C Virus Therapy: Is This Truly Cost Saving?
14/12/2015 Duração: 09minAudible Article by Zobair M. Younossi, M.D., M.P.H.
-
![Ethics and Informed Consent in Patients With Hepatocellular Carcinoma: Changing Roles for Hepatologist and Radiologist]()
Ethics and Informed Consent in Patients With Hepatocellular Carcinoma: Changing Roles for Hepatologist and Radiologist
14/12/2015 Duração: 09minAudible Article by Dirk J. van Leeuwen and Otto M. van Delden
-
![Is It Ethical to Enroll a Patient in a Hepatitis C Virus Clinical Trial When Current Standard of Care Is Highly Effective and Safe?]()
Is It Ethical to Enroll a Patient in a Hepatitis C Virus Clinical Trial When Current Standard of Care Is Highly Effective and Safe?
14/12/2015 Duração: 09minAudible Article by Vijaya L. Rao, M.D., and Christopher Daugherty, M.D.
-
![What Is the Ethical Responsibility of a Provider When Prescribing the New Direct-Acting Antiviral Agents to Patients With Hepatitis C Infection?]()
What Is the Ethical Responsibility of a Provider When Prescribing the New Direct-Acting Antiviral Agents to Patients With Hepatitis C Infection?
14/12/2015 Duração: 09minAudible Article by Zobair Younossi, M.D., M.P.H.
-
![Schistosomiasis: The Ethics of Living Related Liver Transplantation When Deceased Donation Is Not an Option]()
Schistosomiasis: The Ethics of Living Related Liver Transplantation When Deceased Donation Is Not an Option
14/12/2015 Duração: 09minAudible Article by Thomas D. Schiano, M.D. and Rosamond Rhodes, Ph.D.
-
![Noncirrhotic Portal Hypertension: Medical and Endoscopic Management]()
Noncirrhotic Portal Hypertension: Medical and Endoscopic Management
14/12/2015 Duração: 09minAudible Article by S. K. Sarin, Cyriac Abby Philips, Rajeev Khanna
-
![Transplant Tourism Versus Proper Travel for Transplantation]()
Transplant Tourism Versus Proper Travel for Transplantation
25/11/2015 Duração: 09minAudible Article by John S. Gill, M.D., M.S. and Francis L. Delmonico, M.D.
-
![What Is the Ethical (Not Legal) Responsibility of a Physician to Treat Minimal Hepatic Encephalopathy and Advise Patients Not to Drive?]()
What Is the Ethical (Not Legal) Responsibility of a Physician to Treat Minimal Hepatic Encephalopathy and Advise Patients Not to Drive?
25/11/2015 Duração: 09minAudible Article by Mette M. Lauridsen M.D., James B. Wade Ph.D.,jul Jasmohan S. Bajaj M.D.
-
![Systemic Disease Associated With Noncirrhotic Portal Hypertension]()
Systemic Disease Associated With Noncirrhotic Portal Hypertension
25/11/2015 Duração: 09minAudible Article by David Semela, M.D., Ph.D.
-
![Criteria for Liver Transplantation in Hepatocellular Carcinoma]()
Criteria for Liver Transplantation in Hepatocellular Carcinoma
25/11/2015 Duração: 09minAudible Article by Laura Kulik, M.D.
-
![Bone Disease in Cirrhosis]()
Bone Disease in Cirrhosis
25/11/2015 Duração: 09minAudible Article by Nishita Patel M.D. and Santiago J. Munoz M.D.
-
![What Is the Moral Responsibility of Health Care Providers to Report HBV or HCV Status if They Perform Invasive Procedures?]()
What Is the Moral Responsibility of Health Care Providers to Report HBV or HCV Status if They Perform Invasive Procedures?
25/11/2015 Duração: 09minAudible Article by Jessica L. Mellinger, M.D., M.Sc.
-
![Management of Patients with Hepatitis C Virus Resistance–Associated Variants to NS5A Inhibitors: Where Are We Now?]()
Management of Patients with Hepatitis C Virus Resistance–Associated Variants to NS5A Inhibitors: Where Are We Now?
25/11/2015 Duração: 09minAudible Article by Jennifer T. Wells, M.D., Carmen Landaverde, M.D., Julio Gutierrez, and Eric Lawitz, M.D.
-
![Treatment of Patients with Hepatitis C Virus Genotype 3: Where Are We Now?]()
Treatment of Patients with Hepatitis C Virus Genotype 3: Where Are We Now?
25/11/2015 Duração: 09minAudible Article by Carmen Landaverde, M.D., Jennifer T. Wells, M.D., Julio Gutierrez, M.D., Fred Poordad, M.D.
-
![Amebic Liver Abscess]()
Amebic Liver Abscess
14/09/2015 Duração: 09minAudible Article by Judith A. Anesi M.D., and Stephen Gluckman M.D.
-
![Overview of Palliative Care and Hospice Services]()
Overview of Palliative Care and Hospice Services
14/09/2015 Duração: 09minAudible Article by Sara E. Wordingham, M.D. and Keith M. Swetz, M.D., M.A.
-
![Hepatosplenic Candidiasis]()
Hepatosplenic Candidiasis
14/09/2015 Duração: 09minAudible Article by Oliver A. Cornely M.D., Christopher Bangard M.D., and Natalie I. Jaspers M.D.
-
![Recognizing Clonorchiasis: A Foodborne Illness Leading to Significant Hepatobiliary Disease]()
Recognizing Clonorchiasis: A Foodborne Illness Leading to Significant Hepatobiliary Disease
14/09/2015 Duração: 09minAudible Article by Charitha Gowda, M.D., M.P.H.
-
![Issues in the End-Stage Liver Disease Patient for Which Palliative Care Could Be Helpful]()
Issues in the End-Stage Liver Disease Patient for Which Palliative Care Could Be Helpful
14/09/2015 Duração: 09minAudible Article by Paula Cox-North, Ph.D., A.R.N.P.
-
![Pyogenic Liver Abscess]()
Pyogenic Liver Abscess
14/09/2015 Duração: 09minAudible Article by Sarah Longworth M.D. and Jennifer Han M.D., M.S.C.E.
